Adaptogens vs. Clinical Ingredients: Cutting Through the Wellness Noise

What Are Adaptogens, Exactly?

The term "adaptogen" was coined by Soviet scientist Nikolai Lazarev in 1947 to describe substances that increase the body's resistance to stress. The concept was further developed by Israel Brekhman, who established three criteria: an adaptogen must be non-toxic, produce a nonspecific response (meaning it helps the body resist a broad range of stressors), and have a normalizing effect on physiology.

Panossian and Wikman (2010) published a comprehensive review in Pharmaceuticals examining the history and science of adaptogens. The review acknowledged that several adaptogenic plants contain biologically active compounds with measurable effects on stress pathways, including the hypothalamic-pituitary-adrenal (HPA) axis. However, the authors also noted significant gaps in the research: inconsistent dosing across studies, small sample sizes, lack of long-term data, and the challenge of standardizing plant extracts with variable active compound concentrations.

This doesn't mean adaptogens are useless. It means the evidence base is thinner than the marketing suggests — and the difference matters when you're deciding what to put in your body every day.

The Evidence Spectrum

Not all supplement ingredients exist on the same level of scientific validation. Think of it as a spectrum:

At one end, you have ingredients like creatine monohydrate, which has been the subject of over 500 peer-reviewed studies. The International Society of Sports Nutrition published a position stand (Kreider et al., 2017) calling it "the most effective ergogenic nutritional supplement currently available to athletes in terms of increasing high-intensity exercise capacity and lean body mass during training." The effective dose is well-established (3-5g daily), the mechanism of action is clearly understood (phosphocreatine replenishment), and long-term safety data extends over decades.

Magnesium sits in a similarly strong position. Its role in over 300 enzymatic reactions is well-documented. Boyle et al. (2017) published a systematic review in Nutrients confirming associations between magnesium supplementation and improvements in subjective measures of sleep quality. The bioavailability differences between magnesium forms (oxide, citrate, glycinate) are well-characterized, allowing for informed formulation decisions.

In the middle of the spectrum, you find ingredients with promising but still-developing research bases. L-theanine, for instance, has solid evidence for promoting relaxation without sedation (Nobre et al., 2008, Nutritional Neuroscience), but the body of research, while growing, is smaller than what exists for creatine or magnesium.

And toward the other end, you find many popular adaptogens where the evidence is early-stage, inconsistent, or complicated by methodological limitations.

The Ashwagandha Question

Ashwagandha (Withania somnifera) is perhaps the most popular adaptogen in the current wellness landscape. Chandrasekhar et al. (2012) published a randomized, double-blind, placebo-controlled study in the Indian Journal of Psychological Medicine showing that ashwagandha root extract was associated with reductions in serum cortisol levels and self-reported stress scores.

However, a closer look at the research reveals complexity. The study used a specific branded extract (KSM-66) at a specific dose (300mg twice daily). Many commercial products use different extracts, different doses, or different parts of the plant — and the results from one formulation don't necessarily transfer to another. Withanolide content (the primary active compound) varies significantly between products.

More recently, concerns have emerged about ashwagandha's effects on thyroid function. Sharma et al. (2018) published case reports in the Journal of Clinical and Diagnostic Research documenting thyrotoxicosis associated with ashwagandha supplementation. While these are case reports rather than controlled studies, they highlight the reality that "natural" doesn't always mean "without side effects" — especially with long-term use.

The Dose-Response Problem

One of the most fundamental principles in pharmacology is the dose-response relationship: the effect of a substance depends on how much you take. This principle is well-characterized for clinical ingredients. We know that 5g of creatine monohydrate achieves muscle saturation. We know that 200mg of L-theanine promotes alpha brain wave activity. We know that 300mg of magnesium glycinate provides a meaningful proportion of daily magnesium needs.

For many adaptogens, the dose-response relationship is less clear. What's the threshold dose for maca root to affect energy levels? Does 100mg of reishi mushroom extract produce the same effects as 1,000mg? Is there a ceiling effect for rhodiola rosea? In many cases, the research simply hasn't been done at the level of rigor needed to answer these questions definitively.

This creates a practical problem for consumers. Without clear dose-response data, it's impossible to know whether a product contains an effective amount of an ingredient. And for brands prioritizing margins over efficacy, this ambiguity is a feature, not a bug.

The Proprietary Blend Problem

The lack of clear dose-response data for many trendy ingredients intersects dangerously with the supplement industry's use of proprietary blends. A proprietary blend allows a company to list a group of ingredients under a single combined weight, without disclosing how much of each ingredient is actually in the product.

Here's how it works in practice: a label might read "Recovery Blend (2,000mg): creatine monohydrate, ashwagandha, maca root, rhodiola rosea, reishi mushroom." Ingredients are listed in descending order by weight, but the actual amounts are hidden. The blend could be 1,950mg of creatine and dust of everything else — or it could be evenly split, meaning no single ingredient is at a clinically effective dose.

The ISSN has consistently advocated for transparent labeling and clinically validated dosing. When you see a proprietary blend, you're being asked to trust the brand's integrity rather than verify the science for yourself. Transparency in labeling — disclosing exactly how much of each ingredient is in every serving — is the only way consumers can make informed decisions.

Why CHRY Chose Evidence Over Hype

When formulating CHRY, every ingredient had to meet a clear threshold: does this compound have a robust body of peer-reviewed research supporting its use at a specific, well-characterized dose? Ingredients that didn't meet this standard didn't make the cut — regardless of how trendy they were.

The result is a formula built on clinical evidence rather than marketing appeal:

Tart cherry (500mg) — Howatson et al. (2010) and multiple subsequent studies have demonstrated that tart cherry anthocyanins may support post-exercise recovery and the body's inflammatory response. Creatine monohydrate (5g) — the most researched supplement in history, at the exact dose recommended by the ISSN. Magnesium glycinate (300mg) — an essential mineral in one of the most bioavailable forms, supporting muscle function, sleep, and over 300 enzymatic processes. L-theanine (200mg) — shown to promote alpha brain wave activity and relaxation without drowsiness. Apigenin from chamomile (50mg) — a flavonoid with research supporting its calming properties. And beet root (200mg) — providing additional antioxidant compounds and nitric oxide support.

Every ingredient is listed with its exact dose. No proprietary blends. No hidden amounts. No filler ingredients included to pad the label.

The Bottom Line

Adaptogens aren't inherently bad, and clinical ingredients aren't inherently good. What matters is the quality and depth of evidence behind each compound, whether the dose in the product matches the dose used in research, and whether the brand is transparent enough to let you verify those claims yourself.

The wellness industry thrives on novelty and narrative. A new adaptogen with an exotic backstory will always get more Instagram engagement than creatine monohydrate — a white powder that's been studied since the 1990s. But when it comes to what you put in your body every night to support recovery, the boring, well-researched option is often the better one.

Choose evidence. Read labels. Ask for doses. Your body doesn't care about branding — it cares about biochemistry.